In situ rantes and interferon-γ gene expression in pediatric small bowel Crohn's disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 25, Issue 4, 1997, Pages 371-376

  Berrebi, Dominique ^a   Banerjee, Ananda ^a   Paris, Régine ^a   Potet, François ^b   Aigrain, Yves ^a   Emilie, Dominique ^c   Cezard, Jean Pierre ^a   Hugot, Jean Pierre ^a   Navarro, Jean ^a   Peuchmaur, Michel ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Crohn's disease; Granuloma; In situ hybridization; Interferon ; Rantes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; RANTES;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE EXPRESSION; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; ILEITIS; ILEUM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTESTINAL MUCOSA; LYMPH NODES; MACROPHAGES; MALE; MESENTERY; RANTES; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0030884130     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199710000-00001     Document Type: Article

References (29)

1. Baggiolini M, Schnyder J, Bretz U, Dewald B, Ruch W. Cellular mechanisms of proteinase release from inflammatory cells and degradation of extracellular proteins. Ciba Found Symp 1980;75:105-21.
2. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995;146:1287-301.
3. Schall TJ, Jongstra J, Dyer BJ, et al. A human T cell-specific molecule is a member of a new gene family. J Immunol 1988;141: 1018-25.
4. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990;347:669-72.
5. Morson BC, Dawson IMP. Gastrointestinal pathology. 3rd ed. Oxford: Blackwell, 1989;258-77.
6. Tiscopoulos A, Hamid Q, Varney V, et al. Preferential messenger RNA expression of Th1-type cells (IFN γ, IL-2) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol 1992;148:2058-65.
7. Devergne O, Emilie D, Peuchmaur M, Crevon MC, D'Agay MF, Galanaud P. Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 and interferon γ genes. Hum Pathol 1992;23:317-23.
8. Devergne O, Marfaing-Koka A, Schall TT, et al. Production of the Rantes chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells. J Exp Med 1994; 179:1689-94.
9. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the Rantes chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995;154:1870-8.
10. Peuchmaur M, Emilie D, Crevon MC, et al. IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol 1990;136:383-8.
11. Mullin GE, Schmidt A, Braun-Elwert L, et al. Rantes, Mcaf and MIP 2α mRNA levels are increased in the mucosal lesions ot IBD. Gut 1994;7:741A.
12. Mazzuchielli L, Hauser C, Zgraggen K, et al. Differential in situ expression of the genes encoding the chemokines MCP-1 and Rantes in human inflammatory bowel disease. J Pathol 1996;178:201-6.
13. Conlon K, Lloyd A, Chattopathway U, Lukacs N, Kunkel S, Schall T. CD8 + and CD45 RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukine-8 and Rantes. Eur J Immunol 1995;25:751-6.
14. Murphy W, Taub DD, Conlon K, Oppenheim JJ, Kelvin DJ, Longo DL. Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency. Eur J Immunol 1994;24:1823-7.
15. Adams DO. The granulomatous inflammatory responses. Am J Pathol 1976;84:164-91.
16. Lukacs NW, Kunkel SL, Stricter RM, Warmington K, Chensue SW. The role of macrophage inflammatory 1α in Schistosoma mansoni egg-induced granulomatous formation. J Exp Med 1993; 177:1551-9.
17. Fais S, Burgio VL, Silvestri M, Capobianchi MR, Pacchiarotti A, Pallone F. Multinucleated giant cells generation induced by interferon-γ. Lab Invest 1994;71:737-44.
18. Fais S, Capobianchi MR, Silvestri M, Mercuri F, Pallone F, Dianzani F. Interferon expression in Crohn's disease patients: Increased interferon-γ and α mRNA in the intestinal lamina propria mononuclear cells. J Interferon Cytokine Res 1994;14:235-8.
19. Niessner M, Volk BA. Altered TH1/TH2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reverse transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
20. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and interferon-gamma secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-31.
21. Autschbach F, Schürmann G, Quio L, Mertz H, Wallich R, Meuer SC. Cytokine messenger RNA expression status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 1995;426:51-60.
22. Car BD, Eng VM, Schnydee B, et al. Role of Interferon-γ in Interleukin 12-induced pathology in mice. Am J Pathol 1995;147:1693-1707.
23. Rot A, Krieger M, Brunner T, Bischoff SG, Schall TJ, Dahinden CA. Rantes and macrophage inflammatory protein 1 α induce the migration and activation in normal human granulocytes. J Exp Med 1992;176:1489-95.
24. Meurer R, Riper GV, Feeney W, et al. Formation of eosinophil and monocytic intradermal inflammatory sites in the dog by injection of human Rantes but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 α, or human interleukin-8. J Exp Med 1993;178:1913-21.
25. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. Effects of the chemokine Rantes. J Immunol 1994;153:2153-9.
26. Schweizer RC, Welmers BAC, Raajmakers JAM, Zanen P, Lambert J-WJ, Koenderman L. Rantes and interleukin-8 induced responses in normal human eosinophils: Effects of priming with interleukin-5. Blood 1994;83:3697-704.
27. Lopez AF, Sanderson CJ, Gamble JR, Campbell DH, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-4.
28. Dubucquoi S, Janin A, Klein O, et al. Activated eosinophils and interleukin 5 expression in early recurrence of Crohn's disease. Gut 1995;37:242-6.
29. Fromont Hankard G, Brousse N, Cezard JP, Emilie D, Peuchmaur M. In situ Interleukin 5 gene expression in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 1997;24:568-72.